Elevar | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,351 results for “Elevar”

Trials

View all 1202 →

Outcomes of FEVAR and BEVAR to Treat Secondary Type 1 Endoleak After EVAR: A Prospective Multicentre Study

85 participants · First posted Aug 31, 2020

Evaluation of Adjunctive EndoAnchors for EVAR and TEVAR

300 participants · First posted Sep 24, 2019

Post-Implantation Syndrome and Laboratory Markers Following EVAR and TEVAR

300 participants · First posted Jun 11, 2025

Drugs

View all 19 →

rGDF11 (Elevian)

Compleva FHL(Eleva GmbH)

Repleva GAA(Eleva GmbH)

Organizations

View all 15 →

Elevar Therapeutics, Inc.

United States

Eleva GmbH

Germany

Relevare Pharmaceuticals Ltd.

Australia

News

View all 115 →

Relay Therapeutics and Elevar Therapeutics Announce Licensing Agreement for Lirafugratinib

Elevar Therapeutics Addresses Regulatory Trends and Rivoceranib/Camrelizumab Review

Elevar Therapeutics Seeks FDA Approval for Rivoceranib and Camrelizumab Combination in Unresectable Hepatocellular Carcinoma

Page 1 of 136